• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,775.74 -1,092.06
( -1.44%)
Global Indices
Nasdaq
51,069.65 379.68
(0.75%)
Dow Jones
7,605.10 20.47
(0.27%)
Hang Seng
66,385.32 1,692.20
(2.62%)
Nikkei 225
10,420.12 -5.84
(-0.06%)
Forex
USD-INR
95.93 0.16
(0.16%)
EUR-INR
111.54 0.10
(0.09%)
GBP-INR
128.71 -0.01
(-0.01%)
JPY-INR
0.60 0.00
(0.17%)

EQUITY - MARKET SCREENER

Sandu Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524703
INE751D01014
36.3372594
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
22.95
40.58
EPS(TTM)
Face Value()
Div & Yield %
1.83
10
0
 

nirlon ltd
Board of Accelya Solutions India recommends Interim Dividend
Jan 29,2026
Accelya Solutions India announced that the Board of Directors of the Company at its meeting held on 29 January 2026, has recommended a Interim Dividend of Rs.45 per share (i.e.450%), subject to the approval of the shareholders.